Trial Profile
25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China: a Randomized, Single Blind Trial
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms aiRTo-PDR
- 20 Sep 2018 Planned End Date changed from 1 Jul 2017 to 1 Dec 2021.
- 20 Sep 2018 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2020.
- 23 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.